Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Lenhoff, Stig  [Clear All Filters]
Journal Article
Mellqvist, U.-H., Gimsing, P., Hjertner, O., Lenhoff, S., Laane, E., Remes, K., Steingrimsdottir, H., Abildgaard, N., Ahlberg, L., Blimark, C., et al. (2013). Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase III trial.Blood.
Vaht, K., Göransson, M., Carlson, K., Isaksson, C., Lenhoff, S., Sandstedt, A., Uggla, B., Winiarski, J., Ljungman, P., Andersson, P.-O., et al. (2019). High graft-versus-host disease-free, relapse/rejection-free survival and similar outcome of related and unrelated allogeneic stem cell transplantation for aplastic anemia - a nationwide Swedish cohort study.Biol Blood Marrow Transplant.
Nilsson, C., Hulegårdh, E., Garelius, H., Möllgård, L., Brune, M., Wahlin, A., Lenhoff, S., Frödin, U., Remberger, M., Höglund, M., et al. (2019). Secondary acute myeloid leukemia and the role of allogeneic stem cell transplantation in a population-based setting.Biol Blood Marrow Transplant.
Brissot, E., Labopin, M., Beckers, M.M., Socié, G., Rambaldi, A., Volin, L., Finke, J., Lenhoff, S., Kröger, N., Ossenkoppele, G.J., et al. (2014). Tyrosine kinase inhibitors improve long-term outcome of allogeneic hematopoietic stem cell transplantation for adult patients with Philadelphia chromosome positive acute lymphoblastic leukemia.Haematologica.
Lübking, A., Vosberg, S., Konstandin, N.P., Dufour, A., Graf, A., Krebs, S., Blum, H., Weber, A., Lenhoff, S., Ehinger, M., et al. (2015). Young woman with mild bone marrow dysplasia, GATA2 and ASXL1 mutation treated with allogeneic hematopoietic stem cell transplantation.Leuk Res Rep4, 72-5.